2023 ASCO Annual Meeting: Phase 1 Study of Pritumumab in Brain Cancer2023-12-062023-12-06http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttps://www.nascentbiotech.com/wp-content/uploads/2023/12/2023_asco_annual_meeting_poster-5.10.23-final.jpg200px200px
